Table of Contents: Pharmaceutics [26–45 of 45 articles]

• Table of Contents for Year 2010
• New Therapeutic Targets for Mood Disorders, Rodrigo Machado-Vieira, Giacomo Salvadore, Nancy DiazGranados, Lobna Ibrahim, David Latov, Cristina Wheeler-Castillo, Jacqueline Baumann, Ioline D. Henter, and Carlos A. Zarate
  Volume 10 (2010), Pages 713-726
• Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study, Natalie L. Rasgon, Heather A. Kenna, Katherine E. Williams, Bevin Powers, Tonita Wroolie, and Alan F. Schatzberg
  Volume 10 (2010), Pages 321-328
• Table of Contents for Year 2009
• Comparison of Quantitative Structure-Activity Relationship Model Performances on Carboquinone Derivatives, Sorana D. Bolboacă and Lorentz Jäntschi
  Volume 9 (2009), Pages 1148-1166
• Table of Contents for Year 2008
• Conditioned Place Preference Induced by Licit Drugs: Establishment, Extinction, and Reinstatement, Yu Liu, Bernard Le Foll, Yanli Liu, Xi Wang, and Lin Lu
  Volume 8 (2008), Pages 1228-1245
• The Homeopathic Preparation Neurexan® vs. Valerian for the Treatment of Insomnia: An Observational Study, Rainer Waldschütz and Peter Klein
  Volume 8 (2008), Pages 411-420
• Table of Contents for Year 2007
• Treatment of Lowland Frogs From the Spawn Stage with Homeopathically Prepared Thyroxin (10^-30), Helmut Graunke, P. Christian Endler, Waltraud Scherer-Pongratz, Heinz Spranger, Michael Frass, and Harald Lothaller
  Volume 7 (2007), Pages 1697-1702
• Table of Contents for Year 2006
• Pharmaceutical Compounds in Wastewater: Wetland Treatment as a Potential Solution, John R. White, Marco A. Belmont, and Chris D. Metcalfe
  Volume 6 (2006), Pages 1731-1736
• Table of Contents for Year 2005
• Metallic Magnetic Nanoparticles, A. Hernando, P. Crespo, and M. A. García
  Volume 5 (2005), Pages 972-1001
• Table of Contents for Year 2003
• Holistic Medicine IV: Principles of Existential Holistic Group Therapy and the Holistic Process of Healing in a Group Setting, Soren Ventegodt, Niels Jorgen Andersen, and Joav Merrick
  Volume 3 (2003), Pages 1388-1400
• Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin, Tom B. Vree, Erik Dammers, Ivan Ulc, Stefan Horkovics-Kovats, Miroslav Ryska, and IJsbrand Merkx
  Volume 3 (2003), Pages 1332-1343
• Structural Models for Cytochrome P450–Mediated Catalysis, David F.V. Lewis
  Volume 3 (2003), Pages 536-545
• The Use of Spreadsheets for Pharmacokinetic Simulations, JOSEPH Chamberlain
  Volume 3 (2003), Pages 265-278
• Table of Contents for Year 2002
• Molecular Binding Interactions: Their Estimation and Rationalization in QSARs in Terms of Theoretically Derived Parameters, David F.V. Lewis and Howard B. Broughton
  Volume 2 (2002), Pages 1654-1660
• 8-Chloro-cAMP-Related Changes on Mice Uteri, Andrea Actis, Maximo Croci, Emanuel Levin, and Rosa Bergoc
  Volume 2 (2002), Pages 1426-1432
• Variable Absorption of Clavulanic Acid After an Oral Dose of 25 mg/kg of Clavubactin® and Synulox® in Healthy Cats, Tom B. Vree, Eric Dammers, and Eri van Duuren
  Volume 2 (2002), Pages 1369-1378
• Can Drug–Drug Interactions Be Predicted from In Vitro Studies?, Pierre Kremers
  Volume 2 (2002), Pages 751-766
• Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel, Ramin Mirhashemi, J. Fernando Arena, Tony Frudakis, Nicholas Lambrou, Jane Arboleda, Marsha Hunt, Maria Medranda, Hervy Averette, and Manuel Penalver
  Volume 2 (2002), Pages 19-20
• ELUCIDATION OF PROTEIN STRUCTURAL AND PHARMACOPHORE FEATURES BASED ON SEQUENCE CLUSTERING BY COMMON NEIGHBOR COMPARISONS, Richard Kho, Mark Hansen, Brian Baker, Joe Newman, Daniel S. Sem, Richard Jack, and Hugo Villar
  Volume 2 (2002), Pages 17-18
• Table of Contents for Year 2001
• MODULATION OF APOPTOSIS AS A THERAPEUTIC STRATEGY, Kevin J. Tomaselli
  Volume 1 (2001), Pages 104-104
• Big Pharma, Big Bucks, and a Big Pile o’ Pigs,
  Volume 1 (2001), Pages 35-35